These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7017262

  • 1. [Rheological and blood coagulation control during treatment of diffuse kidney diseases].
    Zhavoronkov EK, Potapov VV, Potapova IV.
    Klin Med (Mosk); 1981 Jan; 59(1):57-63. PubMed ID: 7017262
    [No Abstract] [Full Text] [Related]

  • 2. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS.
    Proc Eur Dial Transplant Assoc; 1973 Jan; 10(0):57-90. PubMed ID: 4606240
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative evaluation of the effectiveness of cyclic polychemotherapy and continuous treatment of lupus nephritis with 2 immunodepressants].
    Demin AA, Sentiakova TN.
    Ter Arkh; 1979 Jan; 51(1):71-6. PubMed ID: 556551
    [No Abstract] [Full Text] [Related]

  • 4. [Blood coagulation in the kidney glomerulus in nephritis and nephrotic syndrome and anticoagulative therapy, with special reference to its indication and effectiveness].
    Narita M, Koyama A, Tojo S.
    Nihon Rinsho; 1977 Jun 10; 35(6):2190-6. PubMed ID: 916235
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic glomerulonephritis with heparin and anticoagulants].
    Kinoshita Y, Shimodori T.
    Nihon Rinsho; 1974 Oct 10; 32(10):3121-5. PubMed ID: 4475171
    [No Abstract] [Full Text] [Related]

  • 6. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
    Lee GS, Woo KT, Lim CH.
    Clin Nephrol; 1989 May 10; 31(5):276. PubMed ID: 2661066
    [No Abstract] [Full Text] [Related]

  • 7. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy.
    Kincaid-Smith P, Laver MC, Fairley KF.
    Med J Aust; 1970 Jan 24; 1(4):145-51. PubMed ID: 4907738
    [No Abstract] [Full Text] [Related]

  • 8. [Use of heparin in the complex treatment of lupus nephritis in children].
    Kartasheva VI, Popkova GK, Torik ZhN.
    Vopr Revm; 1976 Jan 24; (1):35-41. PubMed ID: 982931
    [No Abstract] [Full Text] [Related]

  • 9. [Pathogenesis and anticoagulant treatment of autoimmune diseases of the kidneys (review of the literature)].
    Shul'tsev GP, Gilunova NI, Tsalenchuk IaP.
    Ter Arkh; 1971 Nov 24; 43(11):18-23. PubMed ID: 4948318
    [No Abstract] [Full Text] [Related]

  • 10. [Anticoagulant treatment in glomerular nephropathies in children].
    Schneer JH, Chipail A, Constantinescu V, Brumăr OM.
    Pediatria (Bucur); 1973 Nov 24; 22(1):69-73. PubMed ID: 4733565
    [No Abstract] [Full Text] [Related]

  • 11. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M, Kodali BS.
    Int J Obstet Anesth; 2006 Apr 24; 15(2):177-8. PubMed ID: 16488131
    [No Abstract] [Full Text] [Related]

  • 12. [Prevention of clot formation and improvement of blood rheological properties during microsurgical operations. Part II. Comparative studies of small doses of acelysin and low molecular weight heparin enoxaparine (clexane)].
    Vabishchevich AV, Smirnova LA, Roĭtman EV, Fedotov SA, Shibaev EIu, Svetlov VA.
    Anesteziol Reanimatol; 2002 Apr 24; (5):72-6. PubMed ID: 12611307
    [No Abstract] [Full Text] [Related]

  • 13. Coagulation assays.
    Bates SM, Weitz JI.
    Circulation; 2005 Jul 26; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract] [Full Text] [Related]

  • 14. [Use of curantyl in nephritis].
    Rogov VA, Tareeva IE, Kutyrina IM, Nekrasova AA, Tatsievskiĭ VA.
    Klin Med (Mosk); 1988 Feb 26; 66(2):95-7. PubMed ID: 3286998
    [No Abstract] [Full Text] [Related]

  • 15. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E, Sinn W, Lakner V, Ratner M, Tomilina N.
    Z Gesamte Inn Med; 1980 Aug 01; 35(15):Suppl 45-8. PubMed ID: 7467565
    [Abstract] [Full Text] [Related]

  • 16. Prevention of thrombosis during pregnancy.
    Vilela VS, de Jesús NR, Levy RA.
    Isr Med Assoc J; 2002 Oct 01; 4(10):794-7. PubMed ID: 12389343
    [No Abstract] [Full Text] [Related]

  • 17. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB, Sin'kov SV, Klevko VA.
    Anesteziol Reanimatol; 2001 Oct 01; (2):70-5. PubMed ID: 11494909
    [No Abstract] [Full Text] [Related]

  • 18. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Greaves M, Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Thromb Haemost; 2002 Jan 01; 87(1):163-4. PubMed ID: 11848446
    [No Abstract] [Full Text] [Related]

  • 19. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
    Panchenko EP.
    Ter Arkh; 1998 Jan 01; 70(12):71-4. PubMed ID: 10067259
    [No Abstract] [Full Text] [Related]

  • 20. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun 08; 148(23):58-9. PubMed ID: 16826742
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.